SARS-CoV-2 (COVID-19) virus has caused a severe global pandemic since the end of 2019. As treatments, such as vaccination and medication were discovered and distributed, the number of cases, as well as death rate have dropped dramatically. However, reports show that there is an increase of positive cases particularly during winter season and still some deaths or complications following a COVID-19 prognosis. So far, very few oral medications have been developed to treat COVID-19. There is still critical need for more oral medicines to treat COVID-19. Our work will involve using computational tools such as Schrodinger Maestro program in identifying new medicines for COVID-19 by molecular modeling, docking and virtual screening.

Noval oral medicine identification for SARS-CoV-2 infection treatment

Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge. Spring 2023 abstracts, posters, and presentations will launch at the end of March.

ACS Spring 2023

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.